Literature DB >> 26070890

Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1).

Tesfaye Gelanew1, B Katherine Poole-Smith2, Elizabeth Hunsperger2.   

Abstract

Dengue virus (DENV) nonstructural-1 (NS1) glycoprotein is useful for diagnosis of DENV infections in the first 8 days of illness with any of the four serotypes (DENV-1, DENV-2, DENV-3 and DENV-4). However, NS1 diagnostics are less sensitive for secondary DENV infections so the utility of NS1 diagnostics in dengue endemic countries where there is predominantly secondary infections is being questioned. Heat-mediated immunecomplex dissociation (ICD) prior to testing serum samples can significantly improve NS1 test sensitivity in secondary infections but requires monoclonal antibodies (MAbs) reactive to heat-denatured NS1. In order to incorporate a simple heat-mediated ICD step, a crucial step was to develop new MAbs with high affinity and specificity to heat-denatured DENV NS1 protein. In the present study, six new MAbs were isolated from BALB/c mice immunized with recombinant monomeric NS1 of DENV-1 and DENV-2. Characterization using three different methods: indirect ELISA, fixed cell ELISA and western blot revealed that all six MAbs are serotype-cross-reactive and capable of recognizing dimeric and hexameric isoforms as well as heat-denatured NS1 from all four DENV serotypes. No cross-reactivity to NS1 of West Nile virus and Yellow fever virus was observed on western blot and indirect ELISA. Five of the six MAbs mapped to the DENV NS1 region of 105-119 amino acids. The remaining MAb mapped to DENV NS1 region of 25-39 amino acids. These two NS1 regions were found to be highly conserved among all four DENV serotypes by sequences analysis and database comparison. These MAbs were used to develop an NS1 capture ELISA and tested using a small panel of clinical specimens. The results from the NS1 capture ELISA indicated at least a three-fold increase in NS1 antigen detection in heat-denatured samples compared to untreated specimens. Furthermore, artificial immunecomplexed results also demonstrated the binding efficiency of these MAbs to heat denatured NS1. Taken together, these MAbs allow for the incorporation of a heat dissociation step to improve the sensitivity of DENV NS1 antigen detection in secondary infections.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dengue virus; ELISA; Epitope; Immunecomplex; Monoclonal antibody; Nonstructural protein 1; Serotype

Mesh:

Substances:

Year:  2015        PMID: 26070890     DOI: 10.1016/j.jviromet.2015.06.003

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  4 in total

Review 1.  Viral glycoproteins: biological role and application in diagnosis.

Authors:  Nilotpal Banerjee; Sumi Mukhopadhyay
Journal:  Virusdisease       Date:  2016-01-18

2.  Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.

Authors:  Ferdinard Adungo; Fuxun Yu; David Kamau; Shingo Inoue; Daisuke Hayasaka; Guillermo Posadas-Herrera; Rosemary Sang; Matilu Mwau; Kouichi Morita
Journal:  Clin Vaccine Immunol       Date:  2016-08-05

3.  Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1).

Authors:  Tesfaye Gelanew; Elizabeth Hunsperger
Journal:  Virol J       Date:  2018-02-06       Impact factor: 4.099

4.  High performance dengue virus antigen-based serotyping-NS1-ELISA (plus): A simple alternative approach to identify dengue virus serotypes in acute dengue specimens.

Authors:  Tanapan Prommool; Pongpawan Sethanant; Narodom Phaenthaisong; Nattaya Tangthawornchaikul; Adisak Songjaeng; Panisadee Avirutnan; Dumrong Mairiang; Prasit Luangaram; Chatchawan Srisawat; Watchara Kasinrerk; Sirijitt Vasanawathana; Kanokwan Sriruksa; Wannee Limpitikul; Prida Malasit; Chunya Puttikhunt
Journal:  PLoS Negl Trop Dis       Date:  2021-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.